The American Psychosocial Oncology Society (APOS) selected William F. Pirl, M.D., M.P.H., associate director for Cancer Support Services at Sylvester Comprehensive Cancer Center, for the Outstanding Education and Training Award at its national conference on February 16. APOS grants the annual award to an individual who makes substantial contributions to educating or training others in the field.
In an article published in JAMA (Journal of the American Medical Association) Psychiatry, University of Miami Miller School of Medicine psychiatrist Charles B. Nemeroff, M.D., Ph.D., joins colleagues in warning that physicians should carefully weigh the risks and potential benefits before prescribing ketamine as a treatment for depression.
In a comprehensive new review article in Nature Biotechnology, Claes Wahlestedt, M.D., Ph.D., professor of psychiatry and behavioral sciences, and associate dean for therapeutic innovation, at the University of Miami Miller School of Medicine, describes the entire field of oligonucleotide therapeutics as it relates to a wide variety of disorders of the central nervous system.
Women in Academic Medicine, the Office of Diversity and Inclusion, and the Committee of Interns and Residents at the University of Miami Miller School of Medicine hosted the annual Evening of Fellowship on January 23, honoring recent successes and achievements of the Miller School’s women faculty. The event began with networking among attendees from various departments, including many chairs and center directors.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial to determine if two over-the-counter (OTC) medications can diminish alcohol abuse in diagnosed bipolar patients.